These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30992017)

  • 1. Transcriptional positive cofactor 4 promotes breast cancer proliferation and metastasis through c-Myc mediated Warburg effect.
    Luo P; Zhang C; Liao F; Chen L; Liu Z; Long L; Jiang Z; Wang Y; Wang Z; Liu Z; Miao H; Shi C
    Cell Commun Signal; 2019 Apr; 17(1):36. PubMed ID: 30992017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone demethylase PHF8 promotes epithelial to mesenchymal transition and breast tumorigenesis.
    Shao P; Liu Q; Maina PK; Cui J; Bair TB; Li T; Umesalma S; Zhang W; Qi HH
    Nucleic Acids Res; 2017 Feb; 45(4):1687-1702. PubMed ID: 27899639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer.
    Li M; Li A; Zhou S; Lv H; Yang W
    J Hematol Oncol; 2019 Feb; 12(1):14. PubMed ID: 30736840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-myc overexpression drives melanoma metastasis by promoting vasculogenic mimicry via c-myc/snail/Bax signaling.
    Lin X; Sun R; Zhao X; Zhu D; Zhao X; Gu Q; Dong X; Zhang D; Zhang Y; Li Y; Sun B
    J Mol Med (Berl); 2017 Jan; 95(1):53-67. PubMed ID: 27543492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AR-PDEF pathway promotes tumour proliferation and upregulates MYC-mediated gene transcription by promoting MAD1 degradation in ER-negative breast cancer.
    Cao L; Xu C; Xiang G; Liu F; Liu X; Li C; Liu J; Meng Q; Jiao J; Niu Y
    Mol Cancer; 2018 Sep; 17(1):136. PubMed ID: 30217192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human positive cofactor 4 promotes androgen-independent prostate cancer development and progression through HIF-1α/β-catenin pathway.
    Luo P; Jiang Q; Fang Q; Wang Y; Wang Z; Yang J; Tan X; Li W; Shi C
    Am J Cancer Res; 2019; 9(4):682-698. PubMed ID: 31105996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KRT13 promotes stemness and drives metastasis in breast cancer through a plakoglobin/c-Myc signaling pathway.
    Yin L; Li Q; Mrdenovic S; Chu GC; Wu BJ; Bu H; Duan P; Kim J; You S; Lewis MS; Liang G; Wang R; Zhau HE; Chung LWK
    Breast Cancer Res; 2022 Jan; 24(1):7. PubMed ID: 35078507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Feedback Loop Comprising EGF/TGFα Sustains TFCP2-Mediated Breast Cancer Progression.
    Zhao Y; Kaushik N; Kang JH; Kaushik NK; Son SH; Uddin N; Kim MJ; Kim CG; Lee SJ
    Cancer Res; 2020 Jun; 80(11):2217-2229. PubMed ID: 32193292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of TRPS1 stimulates epithelial-mesenchymal transition and metastasis through repression of FOXA1.
    Huang JZ; Chen M; Zeng M; Xu SH; Zou FY; Chen D; Yan GR
    J Pathol; 2016 Jun; 239(2):186-96. PubMed ID: 26969828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The circACTN4 interacts with FUBP1 to promote tumorigenesis and progression of breast cancer by regulating the expression of proto-oncogene MYC.
    Wang X; Xing L; Yang R; Chen H; Wang M; Jiang R; Zhang L; Chen J
    Mol Cancer; 2021 Jun; 20(1):91. PubMed ID: 34116677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of PC4 radiosensitizes non-small cell lung cancer by transcriptionally suppressing XLF.
    Zhang T; Liu X; Chen X; Wang J; Wang Y; Qian D; Pang Q; Wang P
    Cancer Med; 2018 Apr; 7(4):1326-1337. PubMed ID: 29522271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of PC4 increases chemosensitivity of Oxaliplatin in triple negative breast cancer by suppressing mTOR pathway.
    Wang Q; Ma L; Chen L; Chen H; Luo M; Yang W; Liao F; Gong Q; Wang Y; Yang Z; Wu J; Zhang C; Zheng J; Han S; Leng Y; Luo P; Shi C
    Biochem Biophys Res Commun; 2021 Mar; 544():65-72. PubMed ID: 33524870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DOT1L cooperates with the c-Myc-p300 complex to epigenetically derepress CDH1 transcription factors in breast cancer progression.
    Cho MH; Park JH; Choi HJ; Park MK; Won HY; Park YJ; Lee CH; Oh SH; Song YS; Kim HS; Oh YH; Lee JY; Kong G
    Nat Commun; 2015 Jul; 6():7821. PubMed ID: 26199140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADA3 regulates normal and tumor mammary epithelial cell proliferation through c-MYC.
    Griffin NI; Sharma G; Zhao X; Mirza S; Srivastava S; Dave BJ; Aleskandarany M; Rakha E; Mohibi S; Band H; Band V
    Breast Cancer Res; 2016 Nov; 18(1):113. PubMed ID: 27852327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting positive cofactor 4 induces autophagic cell death in MYC-expressing diffuse large B-cell lymphoma.
    Ma L; Gong Q; Chen Y; Luo P; Chen J; Shi C
    Exp Hematol; 2023; 119-120():42-57.e4. PubMed ID: 36642374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UBE2O promotes the proliferation, EMT and stemness properties of breast cancer cells through the UBE2O/AMPKα2/mTORC1-MYC positive feedback loop.
    Liu X; Ma F; Liu C; Zhu K; Li W; Xu Y; Li G; Niu Z; Liu J; Chen D; Li Z; Fu Y; Qian C
    Cell Death Dis; 2020 Jan; 11(1):10. PubMed ID: 31907353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer.
    Wang QS; Kong PZ; Li XQ; Yang F; Feng YM
    Breast Cancer Res; 2015 Feb; 17(1):30. PubMed ID: 25848863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LINC01638 lncRNA activates MTDH-Twist1 signaling by preventing SPOP-mediated c-Myc degradation in triple-negative breast cancer.
    Luo L; Tang H; Ling L; Li N; Jia X; Zhang Z; Wang X; Shi L; Yin J; Qiu N; Liu H; Song Y; Luo K; Li H; He Z; Zheng G; Xie X
    Oncogene; 2018 Nov; 37(47):6166-6179. PubMed ID: 30002443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
    Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
    J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.